Testing effectiveness (Phase 2)Ended earlyNCT04945733
What this trial is testing
Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer
Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
Janssen Pharmaceutical K.K. 62